Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Britt K Erickson
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
408 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- Keimyung University-Dongsan Medical Center
Dalseo-gu, Daegu, South Korea
- Samsung Changwon Hospital
Seoul, Gyeongsangnam-do, South Korea
- Seoul National University Bundang Hospital
Seongnam, Kyeonggi-do, South Korea
- Gangnam Severance Hospital
Seoul, South Korea
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- John Muir Medical Center-Concord
Concord, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- City of Hope Seacliff
Huntington Beach, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- City of Hope at Long Beach Elm
Long Beach, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, United States
- Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, United States
- City of Hope Upland
Upland, California, United States
- John Muir Medical Center-Walnut Creek
Walnut Creek, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Uchealth - Cherry Creek
Denver, Colorado, United States
- Grand Valley Oncology
Grand Junction, Colorado, United States
- Banner North Colorado Medical Center
Greeley, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Nov 2022
- Primary completion
- 31 Oct 2027
- Completion
- 31 Oct 2027
- Last update posted
- 24 Jun 2026
- Registered enrollment
- 360
- Registry id
- NCT05256225
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.